Q&A: Why leading with evidence is necessary for digital therapeutics

Swing Therapeutics CEO Mike Rosenbluth discusses the company's fibromyalgia management tool and what's necessary to make digital therapeutics mainstream.

Related Keywords

Mike Rosenbluth , ,Swing Therapeutics ,Jazz Venture Partners ,Mayo Clinic ,